Meyka AI API is live for developers.Start building.
Advertisement
Embecta Corp.

Embecta Corp. (EMBCV) Stock Overview

Explore Embecta Corp.’s financial performance, market position, analyst ratings, and future outlook.

EMBCVNASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$33.33
$3.43(9.33%)
U.S. Market opens in 47h 5m
Advertisement

Embecta Corp. (EMBCV)

Meyka AI Score

Z

Key Financials

Market Cap1.9B
P/E Ratio0.00
EPS (TTM)N/A
ROE-0.23%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

EMBCV Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Embecta Corp. (EMBCV) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.00 and a market capitalization of 1.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
-29.09%
3-Year Change
-29.09%
5-Year Change
-29.09%
All-Time (Max) Change
-29.09%

Contact Information

(201) 847-6800
1 Becton Drive, Franklin Lakes, NJ, 07054

Company Facts

20,290 Employees
IPO DateMar 21, 2022
CountryUS

Frequently Asked Questions